Clinical Trials on Condiciones crónicas múltiples
Total 438173 results
-
Coordinación de Investigación en Salud, MexicoCompleted
-
NovartisCompletedEfficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (FREEDOMS)Relapsing-remitting Multiple SclerosisCanada, Australia, Israel, Belgium, Czech Republic, Finland, France, Germany, Greece, Lithuania, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Sweden, Switzerland, Turkey, United Kingdom
-
Universita di VeronaCompletedRelapsing-remitting Multiple SclerosisItaly
-
University Hospital Inselspital, BernePharmaPart; Viollier AG, Basel, SwitzerlandCompletedRelapsing-remitting Multiple SclerosisSwitzerland
-
Cantonal Hospital of St. GallenUnknownRelapsing-Remitting Multiple SclerosisSwitzerland
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFinland
-
NeurognosticsCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Universidad de AlmeriaTorrecárdenas Hospital; Almería Health DistrictCompleted
-
NYU Langone HealthNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Thrombocytopenia | Refractory Multiple MyelomaUnited States
-
Nationwide Children's HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingPediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS)United States
-
University Hospital of Mont-GodinneUniversité Catholique de Louvain; Teva Pharmaceuticals USATerminatedRelapsing Remitting Multiple Sclerosis | Motor Deficits | Cognitive Deficits | Secondary-progressive Multiple SclerosisBelgium
-
Friedemann PaulRoche Pharma AGActive, not recruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveGermany
-
Charite University, Berlin, GermanyCompletedRelapsing-Remitting Multiple SclerosisGermany
-
MediciNovaNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes... and other collaboratorsCompletedSafety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple SclerosisMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Providence Multiple Sclerosis CenterBiogenCompletedClinically Isolated Syndrome | Relapsing-remitting Multiple SclerosisUnited States
-
Hoffmann-La RocheActive, not recruitingRelapsing Multiple Sclerosis | Primary Progressive Multiple SclerosisSpain, United States, Italy, Poland, Turkey, New Zealand, Czechia, Brazil
-
Tourcoing HospitalRecruitingDrug Resistance, Multiple, BacterialFrance
-
Fudan UniversityNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingChildhood Cancer | Multiple DiseasesUnited States
-
University Hospital, RouenNot yet recruitingSeptic Shock | Intermittent Fasting | Organ Failure, Multiple
-
National Human Genome Research Institute (NHGRI)CompletedMultiple AbnormalitiesUnited States
-
Bristol-Myers SquibbCompletedMultiple Indications CancerFrance, Poland
-
Bristol-Myers SquibbCompletedMalignancies MultipleUnited States
-
Cellerys AGNovartis; Tetec AG; Scope International AG; Jung Diagnostics GmbHRecruitingRelapsing-remitting Multiple Sclerosis (RRMS)Czechia, Germany, Switzerland
-
Novartis PharmaceuticalsRecruitingRelapsing-Remitting Multiple SclerosisCanada, United States
-
Immunic AGActive, not recruitingRelapsing-Remitting Multiple Sclerosis (RRMS)Poland, Bulgaria, Romania, Ukraine
-
BiogenAbbVieTerminatedRelapsing-Remitting Multiple Sclerosis (RRMS)Italy, United States, Canada, Germany, Puerto Rico
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple Sclerosis (RRMS)Belgium, Mexico, Poland, Romania, Saudi Arabia, Ukraine
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States
-
Novartis PharmaceuticalsTerminatedFatigue in Multiple SclerosisGermany
-
EMD SeronoPfizerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)United States
-
Carmel Medical CenterTerminated
-
Parker Research InstituteVIA University College; University of Southern DenmarkCompletedChronic Conditions, MultipleDenmark
-
Genentech, Inc.CompletedMultiple Sclerosis, Primary Progressive | Relapsing Multiple SclerorsisUnited States, Germany, Canada, Sweden
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Children's Hospital Los AngelesOrganonRecruitingChronic Conditions, MultipleUnited States
-
Neteera Technologies Ltd.CompletedHealthy Subjects | Chronic Conditions, MultipleIsrael, United States
-
Leonardo A. Peyré-TartarugaAline Nogueira Haas; Flávia Gomes MartinezNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveBrazil
-
Cyprus University of TechnologyCyprus Institute of Neurology and GeneticsCompletedMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveCyprus
-
National Center of Neurology and Psychiatry, JapanCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveJapan
-
Casa Sollievo della Sofferenza IRCCSNeurocenter of Southern Switzerland; Associazione Revert ONLUS; Fondazione Cellule...CompletedSecondary-progressive Multiple SclerosisItaly, Switzerland
-
University of Massachusetts, LowellOhio State UniversityCompletedHemiparesis | Primary Progressive Multiple SclerosisUnited States
-
University Medical Center GroningenNot yet recruitingCritically Ill | Organ Failure, Multiple
-
Northeast Iowa Medical Education FoundationUnknownChronic Conditions, MultipleUnited States
-
Banner Life Sciences LLCEnrolling by invitationRelapsing Remitting Multiple SclerosisUnited States, Puerto Rico
-
Haukeland University HospitalOslo University Hospital; University Hospital of North Norway; Helse Stavanger... and other collaboratorsActive, not recruitingRelapsing Remitting Multiple SclerosisNorway, Sweden
-
Banner Life Sciences LLCCompletedRelapsing Remitting Multiple Sclerosis
-
Rocky Mountain MS Research Group, LLCBiogenTerminatedRelapsing Remitting Multiple SclerosisUnited States
-
University Hospital, Gentofte, CopenhagenCompletedMultiple Chemical SensitivitiesDenmark